EIF2A and X-linked retinoschisis: In addition, building on salubrinal's ability to alleviate ER stress and its associated apoptosis, our data suggest that therapeutically targeting the chronic activation of the eIF2α pathway, in combination with AAV‐based gene delivery, offers a novel and effective strategy for treating XLRS.